201. THU0114 Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate in the Avert Trial. (9th June 2015) Authors: Huizinga, T.W.J.; Connolly, S.E.; Johnsen, A.; Zhu, J.; Furst, D.E.; Bykerk, V.P.; Burmester, G.R.; Combe, B.G.; Wong, D.A.; Trouw, L.A.; Toes, R.E.M.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
202. THU0120 Long-term safety of rituximab: 10-year follow-up in the rheumatoid arthritis global clinical trial programme. (23rd January 2014) Authors: van Vollenhoven, R.F.; Emery, P.; Bingham, C.O.; Keystone, E.; Fleischmann, R.; Furst, D.E.; Tyson, N.; Mehbob, A.; Lehane, P.B. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
203. THU0121 Do the Immunological and Ultrasound Characteristics Reflect the Clinical Remission Phenotype in Patients with Rheumatoid Arthritis?. (9th June 2015) Authors: Gul, H.; Isorna Porto, M.J.; Ponchel, F.; Hensor, E.; Wakefield, R.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
204. THU0123 Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis. (23rd January 2014) Authors: Das, S.; Fernandez Matilla, M.; Dass, S.; Vital, E.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
205. THU0124 Low inflammation on magnetic resonance imaging in patients with rheumatoid arthritis that achieved sustained clinical remission on adalimumab: data from the predictra study. (12th June 2018) Authors: Emery, P.; Burmester, G.; Naredo, E.; Lagunes, I.; Zhang, Y.; Wang, X.; Hojnik, M.; Conaghan, P.G. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
206. THU0126 Dose Titration of Biologics for The Treatment of Rheumatoid Arthritis and Ankylosing Spondylitis: A Systematic Literature Review. (15th July 2016) Authors: Lau, C.S.; Gibofsky, A.; Damjanov, N.; Lula, S.; Marshall, L.; Jones, H.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
207. THU0128 Maintenance of Improvements in Workplace and Household Productivity and Physical Function at 2 Years in Early RA Patients with Severe Progressive Disease Who Achieved Sustained Low Disease Activity Following 1 Year of Initial Therapy, with Two Dosing Frequencies of Certolizumab Pegol. (15th July 2016) Authors: Bingham, C.; Emery, P.; Weinblatt, M.; Burmester, G.-R.; Furst, D.E.; Mariette, X.; van Vollenhoven, R.; VanLunen, B.; Purcaru, O.; Bykerk, V.P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
208. THU0136 Long Term Outcomes of Stopping Tumour Necrosis Factor Inhibitors (TNFI) in Patients with Established Rheumatoid Arthritis (RA) Who are in Sustained Remission: Is it Worth the Risk?. (23rd January 2014) Authors: Rakieh, C.; Saleem, B.; Takase, K.; Nam, J. L.; Keen, H.; Wakefield, R. J.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
209. THU0143 EFFECT OF RITUXIMAB OR TUMOUR NECROSIS FACTOR INHIBITORS ON LUNG INFECTION AND 5-YEAR SURVIVAL IN RHEUMATOID ARTHRITIS-ASSOCIATED BRONCHIECTASIS. (2nd June 2020) Authors: MD Yusof, M. Y.; Iqbal, K.; Darby, M.; Lettieri, G.; Vital, E.; Beirne, P.; Dass, S.; Emery, P.; Kelly, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
210. THU0150 Long-Term Safety and Efficacy of SB4 (Etanercept Biosimilar) in Patients with Rheumatoid Arthritis: Comparison between Continuing SB4 and Switching from Etanercept Reference Product To SB4. (15th July 2016) Authors: Emery, P.; Vencovský, J.; Sylwestrzak, A.; Leszczyński, P.; Porawska, W.; Stasiuk, B.; Hilt, J.; Mosterova, Z.; Cheong, S.Y.; Ghil, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗